Floatz logo

MONOCLONAL ANTIBODY BC8

B ALL

Memorial Sloan Kettering Cancer Centermonoclonal_antibodyEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the B ALL cohort.

Asset / SponsorPhaseRating
Dual Target Car-T Cell Therapy
Shenzhen University General Hospital
Phase 1/2CCC

Same molecule, other indications

MONOCLONAL ANTIBODY BC8 is also rated in:

acute myeloid leukemiaDormant
B
Indicative ·
62 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
B
Indicative ·
60 / 100
View asset →
Myelogenous LeukemiaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →